Lea Hyvärinen, MD, PhD (Honorary Professor, Rehabilitation Sciences at Rehabilitation and Education in Blindness or Impairment of Vision in Dortmund, Germany) has described social difficulties caused by types of blindness and visual impairment. In her paper, “Effect of Vision Loss on Communication and Social Skills” she writes that “many problems in communication and social skills are due to misunderstandings [Read More]
News
New Combination Therapy Treats Retinal Damage in Diabetics
Aerpio Therapeutics, Inc. has announced promising results from their “TIME-2” study of AKB-9778 as a treatment for diabetic retinopathy (DR). AKB-9778 alone and in combination with Lucentis® (ranibizumab) improved underlying retinopathy by 10.0%, and 11.4% compared to 8.8% of patients receiving Lucentis® alone. The clinical findings were presented by Pravin U. Dugel, M.D., at the [Read More]
AVA-101 May Extend Time Between Wet AMD Treatments
In 2014, Avalanche Biotechnologies postulated that a single injection of a new gene therapy treatment could possibly stop blood vessel growth and leakage in the wet form of Age-Related Macular Degeneration (AMD) for several years. A single injection of a drug called AVA-101 (aka sFlt-1) could create a kind of biofactory that continuously secretes a therapeutic protein [Read More]
High Dose Statins May Be Effective In Treating Dry AMD
Researchers at Massachusetts Eye and Ear/Harvard Medical School and the University of Crete have found that high doses of statins (cholesterol-lowering medications) can effectively reduce the number of soft drusen deposits in retinas of people with dry age-related macular degeneration (dAMD). The findings from their phase I/II clinical trial were published in the recent issue of [Read More]
Accessible Driving Is On The Horizon
by Dan Roberts A couple of changes are on the horizon which may allow visually impaired people to regain or maintain the pleasure of piloting their own private vehicles whenever and wherever they choose. The most immediate change could come from relaxation of the minimum visual acuity requirements, made possible in part by the development of bioptic [Read More]